The U.S. donor egg IVF services market size was estimated at USD 398.5 million in 2024 and is projected to grow at a CAGR of 4.4% from 2025 to 2030, which is driven by the increasing trend of delayed childbearing, as many women are choosing to focus on their careers and education before starting families. The prevalence of infertility due to lifestyle factors and medical conditions such as polycystic ovary syndrome (PCOS) further fuels demand for donor egg IVF services. Moreover, the high success rates of IVF procedures enhance their attractiveness, encouraging more couples to pursue these options.
In addition, advancements in IVF technologies, such as genetic screening, embryo freezing, and better cryopreservation techniques, have significantly improved success rates, making IVF with donor eggs a more viable option. Increasing public awareness and social acceptance of assisted reproductive technologies (ART) have also contributed to this trend. For instance, the Pew Research Center reported in 2021 that the average age of first-time mothers in the U.S. has increased to 26.3 years, reflecting a societal trend where women prioritize education and career advancement before starting families. This trend has led to increased reliance on ARTs, such as donor egg IVF, as fertility declines with age.
The fresh donor eggs segment dominated the U.S. donor egg IVF services industry with a revenue share of 71.2% in 2024 and is projected to witness the highest CAGR of 9.7% over the forecast period. The segment growth is driven by a strong preference for fresh eggs, which are perceived to offer higher quality and success rates compared to frozen alternatives. The emotion of starting a family leads many couples to choose fresh donor eggs for quicker results. Moreover, the growing availability of egg donors has made fresh eggs more accessible, while the rising cultural acceptance of ARTs encourages more individuals to consider these options. Therefore, easy access to fresh donor egg services is further boosting the demand for U.S. donor egg IVF services.
The frozen donor eggs segment is expected to grow significantly over the forecast period, driven by advancements in vitrification technology, which have enhanced the survival rates of frozen eggs, making them a reliable fertility preservation option. Societal acceptance of egg freezing allows women to delay childbirth while preserving fertility. The growing number of egg banks enhanced accessibility, providing more options for individuals seeking donor eggs. Furthermore, the cost-effectiveness of frozen donor eggs compared to fresh options makes them appealing to many couples.
The fertility clinics segment dominated the U.S. donor egg IVF services industry with the largest revenue share in 2024 and is projected to witness the highest CAGR over the forecast period, which can be attributed to the availability of advanced reproductive technologies such as In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI). These technologies significantly enhance patient outcomes. The clinics often achieve higher success rates compared to hospitals, making them a preferred choice for individuals seeking fertility treatment. In addition, the personalized treatment plans provided by fertility clinics cater to each patient's unique needs, improving satisfaction levels. Therefore, combining expertise, technology, and patient-centered approaches positions fertility clinics as leaders in reproductive health services.
The hospitals and other settings segment is expected to grow significantly over the forecast period, as hospitals offer a broad range of healthcare services, making them a one-stop solution for patients with complex medical conditions who may need additional care during fertility treatments. Hospitals often have access to specialized medical staff and state-of-the-art facilities, enhancing the quality of care for patients seeking infertility treatments. They also tend to attract patients with insurance coverage, as many hospitals are in-network for various health plans. Furthermore, hospitals often have the infrastructure and resources for handling high-risk pregnancies and complications, which appeal to certain patient groups. These factors are expected to contribute to the projected growth of hospitals and other settings in the U.S. donor egg IVF services industry.
Some key companies operating in the market include Shady Grove Fertility, Hamilton Thorne, Seattle Reproductive Medicine, Inc., Fertility Centers of Illinois, and New Hope Fertility Clinic. Companies are undertaking strategic initiatives such as mergers, acquisitions, and product launches to expand their market presence and address the evolving healthcare demands through medical device validation and verification.
Shady Grove Fertility offers various services in the U.S. donor egg IVF services industry, such as fresh and frozen egg donation programs. Its services also include IVF with egg donation, genetic screening, embryo freezing, and fertility preservation. The company also provides access to an extensive network of egg donors through its egg bank and has helped in the birth of over 100,000 babies through its services.
New Hope Fertility Clinic offers a range of advanced fertility treatments and donor egg IVF services, including fresh and frozen donor egg IVF, embryo freezing, and genetic screening. It specializes in personalized care and provides tailored fertility treatment plans to maximize success rates.
In October 2023, Shady Grove Fertility announced the launch of its low-cost IVF Advantage Program in Southern Virginia, aimed at making fertility treatments more affordable for individuals and couples. This program is designed to provide high-quality IVF services at a reduced cost, specifically targeting patients with up to USD 150,000 household income.
In October 2023, CCRM Fertility announced the acquisition of New Hope Center for Reproductive Medicine, a leading fertility clinic based in New York. This strategic acquisition expanded its reach and enhanced its ability to provide personalized, cutting-edge fertility care to a broader patient base.
Report Attribute |
Details |
Market size value in 2025 |
USD 420.0 million |
Revenue forecast in 2030 |
USD 520.5 million |
Growth rate |
CAGR of 4.4% from 2025 to 2030 |
Base year for estimation |
2024 |
Historical data |
2018 - 2023 |
Forecast period |
2025 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2025 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, trends |
Segments covered |
Type,end-use |
Key companies profiled |
Shady Grove Fertility.; Hamilton Thorne; Seattle Reproductive Medicine, Inc. Fertility Centers of Illinois; New Hope Fertility Clinic; Weill Cornell Medicine.; CCRM Fertility.; RMA Network.; RADfertility; Pinnacle |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts country revenue growth and analyzes the latest industry trends in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the U.S. donor egg IVF services market report based on type, end-use, and region:
Type Outlook (Revenue, USD Million, 2018 - 2030)
Fresh Donor Eggs
Frozen Donor Eggs
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Fertility Clinics
Hospitals and Other Settings
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."